Kuntang N. Shen
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Tumor mutation burden predicts aggressiveness and prognosis of gastrointestinal stromal tumor.
Journal: Translational cancer research
Published: November 22, 2025
Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study.
Journal: ImmunoTargets and therapy
Published: August 31, 2025
Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming.
Journal: Cancer research
Published: April 01, 2025
Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study.
Journal: MedComm
Published: June 02, 2024
Safety, effectiveness and the optimal duration of preoperative imatinib in locally advanced gastric gastrointestinal stromal tumors: A retrospective cohort study.
Journal: Cancer medicine
Published: January 04, 2024
COLEC12 Promotes Tumor Progression and Is Correlated With Poor Prognosis in Gastric Cancer.
Journal: Technology in cancer research & treatment
Published: December 19, 2023
Acute myeloid leukemia with positive PICAML-MLLT10 fusion gene: report of 4 cases and literature review
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 07, 2023
Ph-like B-cell acute lymphoblastic leukemia with ZEB2-JAK2 fusion gene positivity: a case report
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 25, 2023
Venetoclax combined with hypomethylating agents induced tumor lysis syndrome in patients with acute leukemia: 7 cases report and literature review
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: August 07, 2023
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 31, 2023
Last Updated: 09/26/2026